Literature DB >> 16425669

The mechanism of action of gabapentin in neuropathic pain.

J Kenneth Baillie1, Ian Power.   

Abstract

Neuropathic pain is a common and potentially treatable cause of considerable lifelong morbidity. Effective pharmacological treatments are scarce, but one group of drugs that has shown promise is the antiepileptics. Gabapentin has become popular as a first-line treatment for neuropathic pain because of its efficacy as an antineuropathic agent and relatively benign side-effect profile. However, its mechanism of action is far from clear. This review discusses the available evidence for the postulated mechanisms of action of gabapentin. Understanding the mechanism of action of this agent may well lead to the development of safer and more effective antineuropathic drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425669

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  11 in total

Review 1.  Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia.

Authors:  Andrew J Holman
Journal:  Curr Pain Headache Rep       Date:  2008-12

Review 2.  Oxycodone combinations for pain relief.

Authors:  R B Raffa; J V Pergolizzi; D J Segarnick; R J Tallarida
Journal:  Drugs Today (Barc)       Date:  2010-06       Impact factor: 2.245

Review 3.  A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain.

Authors:  C Peter N Watson; Ian Gilron; Jana Sawynok
Journal:  Pain Res Manag       Date:  2010 May-Jun       Impact factor: 3.037

4.  Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain.

Authors:  Michael A Tarselli; Kirsten M Raehal; Alex K Brasher; John M Streicher; Chad E Groer; Michael D Cameron; Laura M Bohn; Glenn C Micalizio
Journal:  Nat Chem       Date:  2011-06       Impact factor: 24.427

5.  Role of gabapentin in preventing fentanyl- and morphine-withdrawal-induced hyperalgesia in rats.

Authors:  Xin Wei; Wei Wei
Journal:  J Anesth       Date:  2011-11-03       Impact factor: 2.078

6.  Gabapentin enacarbil - clinical efficacy in restless legs syndrome.

Authors:  Pinky Agarwal; Alida Griffith; Henry R Costantino; Narendra Vaish
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

7.  The Effects of a Gentle Yoga Program on Sleep, Mood, and Blood Pressure in Older Women with Restless Legs Syndrome (RLS): A Preliminary Randomized Controlled Trial.

Authors:  Kim E Innes; Terry Kit Selfe
Journal:  Evid Based Complement Alternat Med       Date:  2012-01-22       Impact factor: 2.629

8.  Gabapentin Effect on Pain Associated with Heroin Withdrawal in Iranian Crack: a Randomized Double-blind Clinical Trial.

Authors:  Behnaz Behnam; Vahid Semnani; Nadia Saghafi; Raheb Ghorbani; Mina Dianak Shori; Samaneh Ghooshchian Choobmasjedi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

9.  Trigeminal Nerve Transection-Induced Neuroplastic Changes in the Somatosensory and Insular Cortices in a Rat Ectopic Pain Model.

Authors:  Satoshi Fujita; Kiyofumi Yamamoto; Masayuki Kobayashi
Journal:  eNeuro       Date:  2019-01-28

10.  Gabapentin inhibits central sensitization during migraine.

Authors:  Yanbo Zhang; Guo Shao; Wei Zhang; Sijie Li; Jingzhong Niu; Dongmei Hu; Mingfeng Yang; Xunming Ji
Journal:  Neural Regen Res       Date:  2013-11-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.